Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma

Journal of Clinical Pathology

Volumn 64, Issue 11, 2011, Pages 990-994

  Hamidov, Zaur ^a   Altendorf Hofmann, Annelore ^a   Chen, Yuan ^a   Settmacher, Utz ^a   Petersen, Iver ^a   Knösel, Thomas ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CELL PROTEIN; COMPLEMENT FACTOR H; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; DESMOCOLLIN; DESMOCOLLIN 1; DESMOCOLLIN 2; DESMOCOLLIN 3; MESOTHELIN; PROTEIN MDM2; PROTEIN PITX1; PROTEIN TLE1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; DESMOSOME; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DESMOCOLLINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054902331     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200099     Document Type: Article

References (21)

1. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelialemesenchymal transition. Bioessays 2001;23:912-23. (Pubitemid 32972691)
2. Brabletz T, Hlubek F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelialemesenchymal transition, mesenchymale epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 2005;179:56-65. (Pubitemid 40976289)
3. Korsching E, Packeisen J, Liedtke C, et al. The origin of vimentin expression in invasive breast cancer: epithelialemesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 2005;206:451-7. (Pubitemid 41025348)
4. Garcea G, Dennison AR, Pattenden CJ, et al. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 2008 Mar 8;9(2):99-132. Review. (Pubitemid 351611725)
5. Kahlert C, Weber H, Mogler C, et al. Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer 2009;101:457-64.
6. Knösel T, Emde A, Schluns K, et al. Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia 2005;7:741-7.
7. Knösel T, Emde V, Schluns K, et al. Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays. Cell Oncol 2006;28:167-75. (Pubitemid 44427400)
8. Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM Classification of Malignant Tumours, 7th edn. Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell, 2010.
9. Kolfschoten IG, van Leeuwen B, Berns K, et al. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 2005;121:849-58. (Pubitemid 40806417)
10. Simon R, Mirlacher M, Sauter G. Immunohistochemical analysis of tissue microarrays. Methods Mol Biol 2010;664:113-26.
11. Fang WK, Gu W, Li EM, et al. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Hum Pathol 2010;41:1456-65.
12. Tselepis C, Chidgey M, North A, et al. Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci U S A 1998;95:8064-9. (Pubitemid 28326066)
13. Funakoshi S, Ezaki T, Kong J, et al. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2. Mol Cancer Res 2008;6:1478-90.
14. Khan K, Hardy R, Haq A, et al. Desmocollin switching in colorectal cancer. Br J Cancer 2006;95:1367-70. (Pubitemid 44760087)
15. Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 2004;15:665-77. (Pubitemid 39550246)
16. Heuser A, Plovie ER, Ellinor PT, et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2006;79:1081-8. (Pubitemid 44853479)
17. Kottke MD, Delva E, Kowalczyk AP. The desmosome: cell science lessons from human diseases. J Cell Sci 2006;119:797-806.
18. Collins JE, Legan PK, Kenny TP, et al. Cloning and sequence analysis of desmosomal glycoproteins 2 and 3 (desmocollins): cadherin-like desmosomal adhesion molecules with heterogeneous cytoplasmic domains. J Cell Biol 1991;113:381-91. (Pubitemid 21909701)
19. Theis DG, Koch PJ, Franke WW. Differential synthesis of type 1 and type 2 desmocollin mRNAs in human stratified epithelia. Int J Dev Biol 1993;37:101-10. (Pubitemid 23145244)
20. Lorch JH, Klessner J, Park JK, et al. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004;279:37191-200. (Pubitemid 39129070)
21. Wu DL, Sui FY, Jiang XM, et al. Methylation in esophageal carcinogenesis. World J Gastroenterol 2006;12:6933-40.